PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Pyridostigmine bromide
Presentation Product Chemical substance Chapter Items dispensed
Pyridostigmine bromide 60mg tablets
1002010Q0AAABAB
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 26,302
Mestinon 60mg tablets
1002010Q0BBAAAB
Mestinon Pyridostigmine bromide Musculoskeletal and Joint Diseases 1,605
Pyridostigmine bromide 12mg/1ml oral solution sugar free
1002010Q0AABLBL
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 200
Pyridostigmine bromide 20mg/5ml oral suspension
1002010Q0AABGBG
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 57
Pyridostigmine bromide 30mg/5ml oral suspension
1002010Q0AABHBH
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 25
Pyridostigmine bromide 180mg modified-release tablets
1002010Q0AABKBK
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 19
Pyridostigmine bromide 60mg/5ml oral suspension
1002010Q0AABIBI
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 18
Pyridostigmine bromide 50mg/5ml oral suspension
1002010Q0AABJBJ
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 17
Mestinon retard 180mg tablets
1002010Q0BBACBK
Mestinon Pyridostigmine bromide Musculoskeletal and Joint Diseases 8
Pyridostigmine bromide 15mg/5ml oral liquid
1002010Q0AAASAS
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 3
Pyridostigmine bromide 30mg/5ml oral solution
1002010Q0AAANAN
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 1
Pyridostigmine bromide 5mg/5ml oral solution
1002010Q0AAAYAY
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases 1
Mestinon 60mg/5ml syrup
1002010Q0BBAEBF
Mestinon Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 10mg tablets
1002010Q0AAAWAW
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 10mg/5ml oral liquid
1002010Q0AAAPAP
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 125mg/5ml oral solution
1002010Q0AAAZAZ
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 150mg/5ml oral liquid
1002010Q0AAALAL
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 180mg/5ml oral liquid
1002010Q0AABDBD
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 200mg/5ml oral solution
1002010Q0AAARAR
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 20mg/5ml oral solution
1002010Q0AAAMAM
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 25mg/5ml oral liquid
1002010Q0AAAKAK
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 28mg/5ml oral solution
1002010Q0AAAQAQ
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 40mg/5ml oral solution
1002010Q0AABBBB
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 4mg/5ml oral liquid
1002010Q0AABEBE
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available
Pyridostigmine bromide 50mg/5ml oral solution
1002010Q0AAAJAJ
Pyridostigmine bromide Pyridostigmine bromide Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.